Table 1.
Age, anthropometric data and clinical characteristics of the women studied
| PsA N = 45 | Ps N = 52 | Control N = 98 | P | |
|---|---|---|---|---|
| Age (years) | 60.5 ± 8.7 | 61.4 ± 9.1 | 60.1 ± 8.4 | 0.95 |
| Weight (kg) | 69.4 ± 8.9 | 71.1 ± 14.2 | 67.8 ± 11.2 | 0.19 |
| Height (m) | 1.50 ± 0.7 | 1.50 ± 0.6 | 1.55 ± 0.6 | 0.97 |
| BMI (kg/m2) | 29.1 ± 3.6 | 26.6 ± 6.2 | 28.1 ± 4.54 | 0.19 |
| Within ideal weight range * | ||||
| N (%) | 7 (15.6) | 9 (17.3) | 25 (25.5) | 0.29 |
| Overweight† | ||||
| N (%) | 17 (37.8) | 22 (42.3) | 40 (40.8) | 0.9 |
| Obese‡ | ||||
| N (%) | 21 (46.7) | 21 (40.4) | 33 (33.7) | 0.31 |
| Ps Duration (years) | 24.8 ± 16.2 | 21.8 ± 17.8 | - | 0.39 |
| PsA Duration (years) | 11 ± 10.5 | - | - | - |
| PASI | 2.2 ± 3.3 | 3.2 ± 3.4 | - | 0.22 |
| HAQ | 0.7 ± 0.5§|| | 0.2 ± 0.3 | 0.1 ± 0.2 | <0.001 |
| DAS28 | 3.7 ± 1.4 | - | - | - |
| PsARC | ||||
| N° of swollen joints | 3.2 ± 2.9 | - | - | - |
| N° of painful joints | 3.5 ± 3.4 | - | - | - |
| Global evaluation of patient (VAS) | 4 ± 2.8 | - | - | - |
| Global evaluation of physician (VAS) | 3.3 ± 2.4 | - | - | - |
| Years since of menopause | 12.7 ± 9.9 | 15.4 ± 10.9 | 12.1 ± 8.6 | 0.22 |
*BMI 18.50 - 24.99 kg/m2; †BMI 25 - 29.99 kg/m2; ‡BMI ≥ 30 kg/m2
DAS28, disease activity score 28; HAQ, health assessment questionnaire; PASI, psoriasis area severity index; PsA, psoriatic arthritis; Ps, psoriasis; PsARC, psoriatic arthritis response criteria; VAS, visual analogue scale.
§P < 0.001 (PsA vs. Ps)
||P < 0.001 (PsA vs. control)